M&A Deal Summary |
|
|---|---|
| Date | 2020-02-19 |
| Target | Koninklijke DSM N.V. - BIO 300 |
| Sector | Life Science |
| Buyer(s) | Humanetics |
| Sellers(s) | DSM-Firmenich |
| Deal Type | Divestiture |
SEARCH BY
Humanetics Corp. is a clinical-stage pharmaceutical company engaged in the accelerated discovery, development and commercialization of proprietary drugs in markets with urgent and unmet needs with a focus on radiation modulators for oncology and medical countermeasures.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: Swaziland M&A | 1 of 1 |
| Year: 2020 M&A | 1 of 1 |
| Category | Company |
|---|---|
| Founded | 1902 |
| Sector | Chemicals |
| Employees | 26,301 |
| Revenue | 12.8B EUR (2024) |
DSM-Firmenich specializes in the development, manufacture, and marketing of performance materials, nutritional and pharmaceutical ingredients, and industrial chemicals. The products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals, automotive and transport, coatings and paint, housing, and electrics & electronics. DSM-Firmenich was founded in 1902 and is based in Kaiseraugst, Switzerland.
| DEAL STATS | # |
|---|---|
| Overall | 14 of 17 |
| Sector: Life Science M&A | 3 of 3 |
| Type: Divestiture M&A Deals | 13 of 16 |
| Country: Swaziland M&A | 1 of 1 |
| Year: 2020 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-06-29 |
Centrient Pharmaceuticals
Rotterdam, Netherlands Centrient Pharmaceuticals is a provider of sustainable antibiotics, next-generation statins and anti-fungals. Centrient develops, produces and sells intermediates, active pharmaceutical ingredients and finished dosage form pharmaceuticals. Centrient Pharmaceuticals is based in Rotterdam, Netherlands. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-06-12 |
Erber AG
Getzersdorf, Austria Erber AG is involved in the field of food and feed safety, focusing on natural feed additives, feed, and food analysis and plant protection with headquarters in Austria/Getzersdorf. Erber consists of BIOMIN, ROMER LABS, SANPHAR, and EFB. Including distribution partners, Erber is represented in more than 140 countries worldwide. The international orientation and in-house research and development are important success factors for the annual growth. Erber was formed in 1983 and is based in Getzersdorf, Austria. |
Buy | €980M |
